551 related articles for article (PubMed ID: 22496789)
1. Efficient commitment to functional CD34+ progenitor cells from human bone marrow mesenchymal stem-cell-derived induced pluripotent stem cells.
Xu Y; Liu L; Zhang L; Fu S; Hu Y; Wang Y; Fu H; Wu K; Xiao H; Liu S; Yu X; Zheng W; Feng B; Huang H
PLoS One; 2012; 7(4):e34321. PubMed ID: 22496789
[TBL] [Abstract][Full Text] [Related]
2. Robust and highly efficient hiPSC generation from patient non-mobilized peripheral blood-derived CD34
Okumura T; Horie Y; Lai CY; Lin HT; Shoda H; Natsumoto B; Fujio K; Kumaki E; Okano T; Ono S; Tanita K; Morio T; Kanegane H; Hasegawa H; Mizoguchi F; Kawahata K; Kohsaka H; Moritake H; Nunoi H; Waki H; Tamaru SI; Sasako T; Yamauchi T; Kadowaki T; Tanaka H; Kitanaka S; Nishimura K; Ohtaka M; Nakanishi M; Otsu M
Stem Cell Res Ther; 2019 Jun; 10(1):185. PubMed ID: 31234949
[TBL] [Abstract][Full Text] [Related]
3. Efficient generation, purification, and expansion of CD34(+) hematopoietic progenitor cells from nonhuman primate-induced pluripotent stem cells.
Gori JL; Chandrasekaran D; Kowalski JP; Adair JE; Beard BC; D'Souza SL; Kiem HP
Blood; 2012 Sep; 120(13):e35-44. PubMed ID: 22898598
[TBL] [Abstract][Full Text] [Related]
4. Efficient hematopoietic redifferentiation of induced pluripotent stem cells derived from primitive murine bone marrow cells.
Pfaff N; Lachmann N; Kohlscheen S; Sgodda M; Araúzo-Bravo MJ; Greber B; Kues W; Glage S; Baum C; Niemann H; Schambach A; Cantz T; Moritz T
Stem Cells Dev; 2012 Mar; 21(5):689-701. PubMed ID: 21732815
[TBL] [Abstract][Full Text] [Related]
5. Growth factors and cytokines upregulate gelatinase expression in bone marrow CD34(+) cells and their transmigration through reconstituted basement membrane.
Janowska-Wieczorek A; Marquez LA; Nabholtz JM; Cabuhat ML; Montaño J; Chang H; Rozmus J; Russell JA; Edwards DR; Turner AR
Blood; 1999 May; 93(10):3379-90. PubMed ID: 10233890
[TBL] [Abstract][Full Text] [Related]
6. Induced pluripotent stem cells expressing elevated levels of sox-2, oct-4, and klf-4 are severely reduced in their differentiation from mesodermal to hematopoietic progenitor cells.
Seiler K; Soroush Noghabi M; Karjalainen K; Hummel M; Melchers F; Tsuneto M
Stem Cells Dev; 2011 Jul; 20(7):1131-42. PubMed ID: 21348597
[TBL] [Abstract][Full Text] [Related]
7. Efficient reprogramming of human cord blood CD34+ cells into induced pluripotent stem cells with OCT4 and SOX2 alone.
Meng X; Neises A; Su RJ; Payne KJ; Ritter L; Gridley DS; Wang J; Sheng M; Lau KH; Baylink DJ; Zhang XB
Mol Ther; 2012 Feb; 20(2):408-16. PubMed ID: 22108860
[TBL] [Abstract][Full Text] [Related]
8. Molecular Analysis of Neutrophil Differentiation from Human Induced Pluripotent Stem Cells Delineates the Kinetics of Key Regulators of Hematopoiesis.
Sweeney CL; Teng R; Wang H; Merling RK; Lee J; Choi U; Koontz S; Wright DG; Malech HL
Stem Cells; 2016 Jun; 34(6):1513-26. PubMed ID: 26866427
[TBL] [Abstract][Full Text] [Related]
9. Fibroblast-Negative CD34-Negative Cells from Human Adipose Tissue Contain Mesodermal Precursors for Endothelial and Mesenchymal Cells.
Navarro A; Marín S; Riol N; Carbonell-Uberos F; Miñana MD
Stem Cells Dev; 2015 Oct; 24(19):2280-96. PubMed ID: 26068131
[TBL] [Abstract][Full Text] [Related]
10. Identification and isolation from either adult human bone marrow or G-CSF-mobilized peripheral blood of CD34(+)/CD133(+)/CXCR4(+)/ Lin(-)CD45(-) cells, featuring morphological, molecular, and phenotypic characteristics of very small embryonic-like (VSEL) stem cells.
Sovalat H; Scrofani M; Eidenschenk A; Pasquet S; Rimelen V; Hénon P
Exp Hematol; 2011 Apr; 39(4):495-505. PubMed ID: 21238532
[TBL] [Abstract][Full Text] [Related]
11. Wharton's jelly mesenchymal stem cell-based or umbilical vein endothelial cell-based serum-free coculture with cytokines supports the ex vivo expansion/maintenance of cord blood hematopoietic stem/progenitor cells.
Li Q; Zhao D; Chen Q; Luo M; Huang J; Yang C; Wang F; Li W; Liu T
Stem Cell Res Ther; 2019 Dec; 10(1):376. PubMed ID: 31806004
[TBL] [Abstract][Full Text] [Related]
12. Residual expression of the reprogramming factors prevents differentiation of iPSC generated from human fibroblasts and cord blood CD34+ progenitors.
Ramos-Mejía V; Montes R; Bueno C; Ayllón V; Real PJ; Rodríguez R; Menendez P
PLoS One; 2012; 7(4):e35824. PubMed ID: 22545141
[TBL] [Abstract][Full Text] [Related]
13. iPSCs-based generation of vascular cells: reprogramming approaches and applications.
Klein D
Cell Mol Life Sci; 2018 Apr; 75(8):1411-1433. PubMed ID: 29243171
[TBL] [Abstract][Full Text] [Related]
14. Porcine brain microvascular endothelial cells support the in vitro expansion of human primitive hematopoietic bone marrow progenitor cells with a high replating potential: requirement for cell-to-cell interactions and colony-stimulating factors.
Davis TA; Robinson DH; Lee KP; Kessler SW
Blood; 1995 Apr; 85(7):1751-61. PubMed ID: 7535587
[TBL] [Abstract][Full Text] [Related]
15. The balance of positive and negative effects of TGF-β signaling regulates the development of hematopoietic and endothelial progenitors in human pluripotent stem cells.
Bai H; Xie YL; Gao YX; Cheng T; Wang ZZ
Stem Cells Dev; 2013 Oct; 22(20):2765-76. PubMed ID: 23758278
[TBL] [Abstract][Full Text] [Related]
16. Human olfactory mucosa multipotent mesenchymal stromal cells promote survival, proliferation, and differentiation of human hematopoietic cells.
Diaz-Solano D; Wittig O; Ayala-Grosso C; Pieruzzini R; Cardier JE
Stem Cells Dev; 2012 Nov; 21(17):3187-96. PubMed ID: 22471939
[TBL] [Abstract][Full Text] [Related]
17. A method for isolating pluripotent/multipotent stem cells from blood by using the pluripotent and germ-line DAZL gene as a marker.
Seligman J; Slavin S; Fabian I
Stem Cells Dev; 2009 Nov; 18(9):1263-71. PubMed ID: 19327014
[TBL] [Abstract][Full Text] [Related]
18. Equine-Induced Pluripotent Stem Cells Retain Lineage Commitment Toward Myogenic and Chondrogenic Fates.
Quattrocelli M; Giacomazzi G; Broeckx SY; Ceelen L; Bolca S; Spaas JH; Sampaolesi M
Stem Cell Reports; 2016 Jan; 6(1):55-63. PubMed ID: 26771353
[TBL] [Abstract][Full Text] [Related]
19. Synergistic actions of hematopoietic and mesenchymal stem/progenitor cells in vascularizing bioengineered tissues.
Moioli EK; Clark PA; Chen M; Dennis JE; Erickson HP; Gerson SL; Mao JJ
PLoS One; 2008; 3(12):e3922. PubMed ID: 19081793
[TBL] [Abstract][Full Text] [Related]
20. Generation of Human iPSCs by Episomal Reprogramming of Skin Fibroblasts and Peripheral Blood Mononuclear Cells.
Febbraro F; Chen M; Denham M
Methods Mol Biol; 2021; 2239():135-151. PubMed ID: 33226617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
